NCT06816693Completed
Exploratory Study of the Usability, Feasibility, and Perception for Tele-cardiac Rehabilitation (Tele-CR) Program
Feasibility Study of a Mobile Application (App)-Based Tele-cardiac Rehabilitation (Tele-CR) Program for Patients With Coronary Heart Disease (CHD): Mixed Methods
Source: ClinicalTrials.gov · Last updated 20 Mar 2026
Brief summary (registry, in English)
The goal of this mixed prospective observational and qualitative studies is to evaluate the usability of a newly developed application (App) and the feasibility and perception of a 12 weeks tele-cardiac rehabilitation (tele-CR) program. The main question it aims to answer is: Does tele-CR program intervention a acceptance feasibility in coronary heart disease patients? The findings will guide subsequent intervention design studies.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 34 (actual)
- First submitted
- 22 Jan 2025
- Start date
- 31 Mar 2025
- Primary completion date
- 31 Jan 2026
- Lead sponsor
- Chang Gung University of Science and Technology
- Diseases
- Coronary artery disease
- NCT number
- NCT06816693
What you commit to
- Study type: Observational
- Participants enrolled: 34
- From 31 Mar 2025 to the primary completion date, 31 Jan 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study design.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Planning to receive surgery (e.g., coronary artery bypass graft).
Other illness
- Level IV on the New York Heart Association Functional Classification.
- Have a history of severe arrhythmia (e.g., ventricular tachycardia, ventricular fibrillation, complete atrioventricular block).
- Combined with other serious heart diseases (e.g., congenital heart disease, cardiomyopathy).
- Mental disorders, end-stage renal disease and other systemic diseases diagnosed by a physician.
- Severe infection, injury, surgery (e.g., coronary artery bypass graft) or cancer treatment has occurred in the past three months.
- Physical activities are affected by neurological, respiratory, skeletal, or peripheral vascular diseases.
- Restricted use of the App due to sensory or cognitive impairment.
Lab values
- Left ventricular ejection fraction≦40%.
Other
- Already participated in other clinical trials.
Who the study is looking for
- The main diagnosis at admission of CHD.
- Age ≥20 years.
- Owns an iOS or Android smartphone and can use it.
- Conscious, clear and can communicate.
- Agrees to participate in the research after explanation and is willing to use the App.
Age in the registry: 20 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Chang Gung Memorial Hospital Coordinator of this site? Confirm its status | Taoyuan | Taiwan | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.